Rerouting DOT1L inhibitors in leukemia. (2020)
Attributed to:
Understanding granule disorders of myeloid cells by unravelling the interactome and function of the Nbeal2 protein
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1182/blood.2020007352
PubMed Identifier: 33091135
Publication URI: http://europepmc.org/abstract/MED/33091135
Type: Journal Article/Review
Volume: 136
Parent Publication: Blood
Issue: 17
ISSN: 0006-4971